GeoVax Labs, Inc. cotiza a 0.28 USD y tiene una capitalización bursátil de $3M. En los últimos 12 meses ha facturado $0 con un margen de flujo de caja libre del -863.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive…
| Periodo | 2026-07 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.97 | $-2.62 | — | $-7.75 |
| Estimado | $-2.15 | $-0.84 | $-5.35 | $-6.62 |
| Sorpresa | +54.9% | -211.9% | — | -17.1% |
| Métrica | GOVX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -869.3% | -38.6% | -830.7% |
| Net Margin | -862.3% | -33.6% | -828.8% |
| FCF Margin | -863.8% | -13.9% | -849.9% |
| ROE | -561.1% | -40.4% | -520.8% |
| ROA | -338.5% | -32.0% | -306.4% |
| Current Ratio | 2.74 | 2.84 | -0.10 |
| Debt / Equity | — | 0.28 | — |